A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects

Clinical trial NCT05328583 · UNKNOWN

Trial details

NCT number: NCT05328583
Sponsor: RetroLead (Shanghai) BioPharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-1 (HIV-1) Infection

Start date: 2022-04-15
Primary completion: 2023-03-10
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.